| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 60/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Parecoxib is a water soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, Parecoxib 99%/198470-84-7. Function of Parecoxib Sodium it can be used perioperatively when patients are unable to take oral medications. Application of Parecoxib Sodium It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac(Toradol) is used in the United Parecoxib 99%/198470-84-7 States. However, unlike ketorolac, parecoxib has no effect on platelet function and therefore does not promote bleeding during or after surgery. |
|
Analysis
|
Specification
|
Result
|
Test method
|
|
Physical Description
|
|
|
|
|
Appearance
|
White Powder
|
White Powder |
Visual
|
|
Odor
|
Characteristic
|
Characteristic
|
Organoleptic
|
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
|
Chemical Tests
|
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
|
Microbiology Control
|
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
|
Conclusion
|
Complies with the standards.
|
||
|
General Status
|
Non-GMO, ISO Certificated.
|
||
){kind=link}